Darren Chan

Lipidomic Analysis Reveals Drug-Induced Lipoxins in Glaucoma Treatment

The paper identifies drug-induced lipoxins in glaucoma treatment, showing latanoprost increases lipoxin A4, which reduces inflammation and lowers intraocular pressure.

Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large molecules

This paper demonstrates that dual targeting of TfR and CD98hc enhances brain exposure of large molecules compared to single-target approaches.

Transferrin receptor-mediated transport at the blood-brain barrier is elevated in early development but maintained across adult aging

This study investigates TfR-mediated BBB transport in mice across development and aging, finding elevated transport in early development and stability across adulthood, including in an AD model.

Engineering anti-amyloid antibodies with transferrin receptor targeting improves brain biodistribution and mitigates ARIA

This study develops an antibody transport vehicle targeting the transferrin receptor to improve brain delivery of anti-amyloid antibodies, reducing ARIA-like lesions and vascular inflammation in a mouse model.

Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution compared to standard antibodies

This study compares the biodistribution of Fc-engineered molecules targeting BBB receptors with standard antibodies, showing distinct CNS and peripheral organ targeting.

Molecular architecture determines brain delivery of a transferrin-receptor targeted lysosomal enzyme

The paper compares brain delivery and efficacy of two TfR-targeted enzyme fusions in MPS II mice, finding the moderate-affinity ETV:IDS has better brain exposure and substrate reduction than the high-affinity IgG:IDS.